Scarica l'app Stockscreener
75.55
0.00%
0.2651
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$75.82
Aprire:
$75.83
Volume 24 ore:
484.66K
Relative Volume:
0.36
Capitalizzazione di mercato:
$8.92B
Reddito:
$12.50B
Utile/perdita netta:
$314.00M
Rapporto P/E:
30.97
EPS:
2.44
Flusso di cassa netto:
$421.00M
1 W Prestazione:
-2.97%
1M Prestazione:
-0.95%
6M Prestazione:
+7.27%
1 anno Prestazione:
+6.38%
Intervallo 1D:
$74.90
$76.01
Intervallo di 1 settimana:
$74.07
$80.03
Portata 52W:
$60.56
$82.49
Henry Schein Inc Stock (HSIC) Company Profile
Nome
Henry Schein Inc
Settore
Industria
Telefono
(631) 843-5500
Indirizzo
135 DURYEA RD, MELVILLE, NY
Confronta HSIC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
HSIC
Henry Schein Inc
|
75.79 | 8.93B | 12.50B | 314.00M | 421.00M | 2.44 |
|
MCK
Mckesson Corporation
|
836.24 | 101.70B | 387.09B | 4.23B | 6.01B | 32.12 |
|
COR
Cencora Inc
|
348.62 | 67.10B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
CAH
Cardinal Health Inc
|
213.46 | 49.48B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
AHG
Akso Health Group Adr
|
1.44 | 796.34M | 2.22M | -5.63M | -1.68M | -0.24 |
Henry Schein Inc Stock (HSIC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-08-26 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-07-25 | Downgrade | Stifel | Buy → Hold |
| 2025-07-14 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-02-14 | Iniziato | Wells Fargo | Equal Weight |
| 2025-01-06 | Aggiornamento | BofA Securities | Underperform → Buy |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-07-22 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2023-12-12 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-11-10 | Aggiornamento | Stifel | Hold → Buy |
| 2022-08-08 | Aggiornamento | UBS | Sell → Neutral |
| 2022-07-21 | Downgrade | Goldman | Buy → Neutral |
| 2022-06-14 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-05-13 | Ripresa | Credit Suisse | Outperform |
| 2022-01-31 | Iniziato | Morgan Stanley | Underweight |
| 2022-01-07 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2021-10-01 | Ripresa | Credit Suisse | Neutral |
| 2021-02-08 | Ripresa | Piper Sandler | Overweight |
| 2021-01-04 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2020-11-03 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2020-05-06 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2020-04-07 | Aggiornamento | Goldman | Neutral → Buy |
| 2020-04-02 | Aggiornamento | Wolfe Research | Peer Perform → Outperform |
| 2020-01-09 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2020-01-02 | Aggiornamento | Evercore ISI | Underperform → In-line |
| 2019-08-07 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2019-05-30 | Iniziato | Wolfe Research | Underperform |
| 2019-05-15 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2019-04-18 | Iniziato | Guggenheim | Buy |
| 2019-01-17 | Iniziato | UBS | Sell |
| 2019-01-03 | Downgrade | Evercore ISI | In-line → Underperform |
| 2019-01-02 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2018-11-08 | Reiterato | Barrington Research | Outperform |
| 2018-10-25 | Downgrade | Edward Jones | Hold → Sell |
| 2018-10-19 | Ripresa | Goldman | Neutral |
| 2018-10-04 | Reiterato | Robert W. Baird | Outperform |
| 2018-08-07 | Reiterato | Stifel | Hold |
| 2018-04-24 | Downgrade | Goldman | Buy → Neutral |
| 2018-04-04 | Aggiornamento | Leerink Partners | Mkt Perform → Outperform |
Mostra tutto
Henry Schein Inc Borsa (HSIC) Ultime notizie
Why Henry Schein (HSIC) is a Top Value Stock for the Long-Term - sharewise.com
Henry Schein Taps Former Thermo Fisher Exec as New CEO - Modern Distribution Management
Will Henry Schein’s (HSIC) New External CEO and Governance Shift Reframe Its Leadership Narrative? - simplywall.st
Henry Schein Names Thermo Fisher Exec Frederick Lowery as CEO - Medical Product Outsourcing
Frederick Lowery named new CEO of Henry Schein, effective March 2026 - Investing.com Nigeria
Leadership transition at Henry Schein: Frederick M. Lowery to take over as CEO - Dental Tribune US
Henry Schein names Frederick M. Lowery as new CEO - Newsday
Henry Schein Appoints Frederick M Lowery as New CEO - Orthodontic Products
Henry Schein, Inc. Announces Management Changes - marketscreener.com
Henry Schein, Inc. Appoints Frederick M. Lowery as Chief Executive Officer, Effective March 2, 2026 - marketscreener.com
Henry Schein names Frederick Lowery as new CEO - Long Island Business News
Henry Schein appoints industry veteran Frederick M. Lowery as new CEO - Oral Health Group
Henry Schein names new CEO - HME News
Henry Schein, Inc. (HSIC) Announces New CEO Appointment - GuruFocus
Henry Schein picks new CEO with significant healthcare distribution experience - MassDevice
Henry Schein (HSIC) Appoints Frederick Lowery as New CEO - GuruFocus
Henry Schein Names Frederick Lowery Chief Executive - marketscreener.com
Henry Schein appoints new CEO amid governance changes - TipRanks
Henry Schein Appoints Frederick M. Lowery as Chief Executive Officer - citybiz
Henry Schein Names Frederick M. Lowery as Chief Executive Officer - The Joplin Globe
Henry Schein, Inc. Announces the Appointment of Frederick M. Lowery to the Board of Directors, Effective March 2, 2026 - marketscreener.com
Henry Schein Stock Tests Investor Patience As Healthcare Distribution Re?rates - AD HOC NEWS
Can Henry Schein Inc. stock maintain growth trajectoryQuarterly Portfolio Review & Fast Gain Stock Trading Tips - Улправда
Henry Schein (HSIC) Q1 Earnings Beat Estimates - sharewise.com
Is Henry Schein (HSIC) Pricing Look Attractive After Recent 4.5% Weekly Gain - simplywall.st
Will Henry Schein Inc. stock split attract more investorsWeekly Gains Summary & Real-Time Chart Pattern Alerts - Улправда
Is Henry Schein Inc. stock a safe investment in uncertain markets2025 Trade Ideas & Daily Chart Pattern Signal Reports - ulpravda.ru
Is Henry Schein Inc. stock a bargain at current levels2025 Market Sentiment & Risk Managed Investment Signals - ulpravda.ru
Henry Schein (HSIC) Valuation Check As CEO Retirement Delay Puts Succession Planning In Focus - simplywall.st
Bank of America Securities Reaffirms Their Buy Rating on Henry Schein (HSIC) - The Globe and Mail
The Truth About Henry Schein Inc: Is This ‘Boring’ Stock Secretly a Power Play? - AD HOC NEWS
Henry Schein Inc. stock outperforms competitors on strong trading day - MarketWatch
Henry Schein’s Stock Under Pressure: Is Wall Street Turning Too Pessimistic on SCHE? - AD HOC NEWS
The Truth About Henry Schein Inc: Quiet Dental Giant Or Sleeper Stock You’re Sleeping On? - AD HOC NEWS
New Henry Schein CEO expected by mid-January as Bergman extends tenure - MedTech Dive
Aug Technicals: Is Henry Schein Inc stock a bargain at current levels2025 Bull vs Bear & Verified Short-Term Trading Plans - moha.gov.vn
Can Henry Schein Inc stock surprise with earnings upsideInflation Watch & Verified Swing Trading Watchlists - moha.gov.vn
Dow Update: What technical signals suggest for Henry Schein Inc stockBear Alert & Daily Profit Maximizing Trade Tips - moha.gov.vn
List of 35 Acquisitions by Henry Schein (Jan 2026) - Tracxn
Henry Schein Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Earnings Beat: Why Henry Schein Inc. stock remains undervalued2025 Pullback Review & Weekly High Potential Stock Alerts - moha.gov.vn
Why Henry Schein, Inc. (NASDAQ:HSIC) Could Be Worth Watching - 富途牛牛
Henry Schein (NASDAQ:HSIC) Has More To Do To Multiply In Value Going Forward - Yahoo Finance
One Fund Bought Up Henry Schein Stock Amid Record Quarterly Results and a New $200 Million Efficiency Plan - AOL.com
Henry Schein to announce next CEO by mid-January - MassDevice
Interview: Brian Weatherly, CEO of Henry Schein One - Adam Mendler
One Fund Bought Up Henry Schein Stock Amid Record Quarterly Results and a New $200 Million Efficiency Plan - The Motley Fool
Henry Schein Joins J.P. Morgan Healthcare Event - Dentistry Today
Henry Schein to Participate in the J.P. Morgan Conference in January - Business Wire
Marathon Asset Management Ltd Cuts Stock Position in Henry Schein, Inc. $HSIC - MarketBeat
Henry Schein Earnings Notes - Trefis
Henry Schein Inc Azioni (HSIC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Henry Schein Inc Azioni (HSIC) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| DANIEL WILLIAM K | Director |
Aug 07 '25 |
Buy |
67.08 |
10,000 |
670,800 |
10,000 |
| LASKAWY PHILIP A | Director |
Mar 19 '25 |
Sale |
71.04 |
2,604 |
184,999 |
24,805 |
| Connett Bradford C | CEO, NA Distribution Group |
Mar 19 '25 |
Sale |
71.15 |
4,036 |
287,161 |
62,688 |
4.48%
82.02%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):